Also listed on Medtor LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Sep 5, 2041 · High confidence
20-year base term ends Feb 4, 2039
Held by Biointellisense, Inc.
Filed Feb 4, 2019 as application 16/266,442 · Granted Jun 4, 2024
Base term plus 944 days of patent term adjustment (USPTO delay)
Today
2019
2041
Clock starts
Feb 4, 2019
Feb 4, 2019
Term ends
Sep 5, 2041
Sep 5, 2041
Granted
Jun 4, 2024
Jun 4, 2024
base term
patent term adjustment
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
944
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
This patent's term runs 944 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 4, 2019, when this application, 16/266,442, was filed | Feb 4, 2039 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +944 days, USPTO patent term adjustment record | Sep 5, 2041 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 5, 2041 | High confidence |
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 5, 2019 Reel 48240, frame 473 | Dietiker, Thomas | Medtor LLC | Assignment of Assignor's Interest |
| Dec 3, 2020 Reel 54538, frame 882 | Medtor, Inc.; Dietiker, Thomas | Osi Optoelectronics, Inc. | Security Interest |
| Aug 6, 2021 Reel 57113, frame 46 | Medtor LLC | Medtor, Inc. | Entity Conversion and Name Change |
| Nov 16, 2021 Reel 58159, frame 68 | Osi Optoelectronics, Inc. | Medtor, Inc.; Dietiker, Thomas | Release of Security Interest |
| Nov 16, 2021 reel/frame not recorded | Osi Optoelectronics, Inc. | Medtor, Inc. | Release of Security Interest |
| Nov 16, 2021 reel/frame not recorded | Osi Optoelectronics, Inc. | Dietiker, Thomas | Release of Security Interest |
| May 3, 2023 Reel 63523, frame 935 | Medtor, Inc.; Biointellisense, Inc. | Biointellisense, Inc. | Merger and Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Sep 2041
Term ends Sep 5, 2041. Maintenance fees still fall due before then
Note
The 944 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
2
later US patents cite this one
Fewer than half of the utility patents granted in 2024 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.